Détente sells gene database system to UK hospital
29 May, 2003 by Jeremy TorrSydney-based clinical systems company Détente Systems has scored a major international coup, selling its gene database system to the prestigious Great Ormond Street Hospital (GOSH) in the UK.
Mystery investor buys 13.5 per cent of Brain Resource Co
29 May, 2003 by Jeremy TorrSydney's Brain Resource Company, a compiler of global brain function databases, has benefited from a 13.5 per cent, $AUD2.5 million share buy from a mystery investor.
Bioinformatics boost in Queensland
22 May, 2003 by Pete YoungThe first alliance of Australian bioinformatics groups to be created with a commercial focus has sprung up in Queensland.
Return of a proteomics pioneer
21 May, 2003 by Iain ScottA new company established by proteomics pioneer Dr Brad Walsh has been chosen by a global leader to be its regional proteomics centre.
Proteomics at your service
20 May, 2003 by Iain ScottThe service centre model for proteomics has taken off in the last few years. Iain Scott looks at some of the groups around Australia who are staking out their claims in this area.
Building on the foundations
16 May, 2003 by Jeremy TorrOther states may have more surface glitz and glamour, but many local experts agree NSW has the makings of a solid, healthy and expanding biotech industry. Jeremy Torr investigates.
Proteomic study backs up link between plaque and heart disease
14 May, 2003 by Jeremy TorrMelbourne University proteomic research has indicated a possible link between oral hygiene and heart disease.
Gene patents: pathologists call on govts to challenge GTG
12 May, 2003 by Melissa TrudingerA row is brewing between the Royal College of Pathologists Australasia and Genetic Technologies, the Melbourne-based biotechnology company that last year obtained an exclusive license to offer Myriad Genetics' BRCA1 and BRCA2 breast cancer susceptibility tests in Australia and New Zealand.
Its genome sequenced, SARS patents proliferate
12 May, 2003 by Jeremy TorrFollowing intense activity around the globe, researchers have identified critical aspects of the SARS genome -- and now the race is on to file patents.
Queensland bio braces for the future
12 May, 2003 by Pete YoungThanks to a massive infrastructure funding boost from a government led by bio-enthusiast Premier Peter Beattie, Queensland got off to a fast start in biotechnology. But, asks Pete Young, is the venture capital bottleneck pushing its plans off track?
Flying the flag for bioinformatics
29 April, 2003 by David BraueDavid Braue discovers why the upcoming ISMB conference in Brisbane is likely to boost the profile of bioinformatics in Australia.
Winds of change
29 April, 2003 by Pete YoungAs the winds of change whistle through the life sciences industry in Australia and overseas, some bio-IT trends are also changing, a poll of the major vendors reveals.
Happy together
24 April, 2003 by David BinningWhen it comes to clustering, Australian biotech could take a few lessons from the nation's wine industry -- and not just the grapes, David Binning finds.
Nobel laureate Sulston critical of 'greedy' IP
24 April, 2003 by Graeme O'NeillHistory students and trivia buffs in the distant future time will be grateful for one of history's little coincidences -- the Human Genome Project will be completed this year, 2003, a neat half-century after the elucidation of the structure of DNA.
Vindication for proteomics in research on ageing
23 April, 2003 by Graeme O'NeillGeneticists at the National Human Genome Research Institute in Washington last week celebrated the publication of the identity of the faulty gene involved in a devastating premature-ageing disorder. But it was only half the story -- an Australian collaboration has provided a bigger picture, reports Graeme O'Neill.
